Effect of Ring Fluorination on the Pharmacology of Hallucinogenic Tryptamines
The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
A series of fluorinated analogues of the hallucinogenic tryptamines N,N-diethyltryptamine (DET), 4-hydroxy-N,N-dimethyltryptamine (4-OH-DMT, psilocin), and 5-methoxy-DMT was synthesized to investigate possible explanations for the inactivity of 6-fluoro-DET as a hallucinogen and to determine the effects of fluorination on the molecular recognition and activation of these compounds at serotonin receptor subtypes. The target compounds were evaluated using in vivo behavioral assays for hallucinogen-like and 5-HT(1A) agonist activity and in vitro radioligand competition assays for their affinity at 5-HT(2A), 5-HT(2C), and 5-HT(1A) receptor sites. Functional activity at the 5-HT(2A) receptor was determined for all compounds. In addition, for some compounds functional activity was determined at the 5-HT(1A) receptor. Hallucinogen-like activity, evaluated in the two-lever drug discrimination paradigm using LSD-trained rats, was attenuated or abolished for all of the fluorinated analogues. One of the tryptamines, 4-fluoro-5-methoxy-DMT (6), displayed high 5-HT(1A) agonist activity, with potency greater than that of the 5-HT(1A) agonist 8-OH-DPAT. The ED(50) of 6 in the two-lever drug discrimination paradigm using rats trained to discriminate the 5-HT(1A) agonist LY293284 was 0.17 micromol/kg, and the K(i) at [(3)H]8-OH-DPAT-labeled 5-HT(1A) receptors was 0.23 nM. The results indicate that fluorination of hallucinogenic tryptamines generally has little effect on 5-HT(2A/2C) receptor affinity or intrinsic activity. Affinity at the 5-HT(1A) receptor was reduced, however, in all but one example, and all of the compounds tested were full agonists but with reduced functional potency at this serotonin receptor subtype. The one notable exception was 4-fluoro-5-methoxy-DMT (6), which had markedly enhanced 5-HT(1A) receptor affinity and functional potency. Although it is generally considered that hallucinogenic activity results from 5-HT(2A) receptor activation, the present results suggest a possible role for involvement of the 5-HT(1A) receptor with tryptamines.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“which may be a necessary property of effective hallucinogens.”
From Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans. (2021) · cites this paper as [14]
In the citing paper
“The corresponding Ki values against [123I]-DOI indicated ten-fold higher affinity at 5HT2A sites [10,14], which is presumably indicative of the greater competition between an agonist drug at agonist-labelled receptors, as has been established for the case of dopamine D2/3 receptors [46].”
From Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans. (2021) · cites this paper as [14]
Citations
Cites
A SIMPLIFIED METHOD OF EVALUATING DOSE-EFFECT EXPERIMENTS
LITCHFIELD, J. T., & WILCOXON, F. (1949) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)03549-9 · Cited by 7,812
How good is fluorine as a hydrogen bond acceptor?
Howard, J. A. K., Hoy, V. J., O'Hagan, D., & Smith, G. T. (1996) · Tetrahedron · doi:10.1016/0040-4020(96)00749-1 · Cited by 737
Titeler, M., Lyon, R. A., & Glennon, R. A. (1988) · Psychopharmacology · doi:10.1007/bf00176847 · Cited by 343
Schreiber, R., Brocco, M., Audinot, V, Gobert, A., Veiga, S., & Millan, M. J. (1995) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)09485-6 · Cited by 300
CYCLOPENTADIENYL COMPOUNDS OF Sc, Y, La, Ce AND SOME LANTHANIDE ELEMENTS
Wilkinson, G., & Birmingham, J. M. (1954) · Journal of the American Chemical Society · doi:10.1021/ja01652a114 · Cited by 272
Human psychopharmacology of N,N-dimethyltryptamine
Strassman, R. J. (1995) · Behavioural Brain Research · doi:10.1016/0166-4328(96)00081-2 · Cited by 261
Differential interactions of indolealkylamines with 5-hydroxytryptamine receptor subtypes
Mckenna, D. J., Repke, D. B., Lo, L., & Peroutka, S. J. (1990) · Neuropharmacology · doi:10.1016/0028-3908(90)90001-8 · Cited by 192
Characteristics of C-F Systems
Smart, B. E. (1994) · Organofluorine Chemistry · doi:10.1007/978-1-4899-1202-2_3 · Cited by 187
Inter-animal olfactory cues in operant drug discrimination procedures in rats
Extance, K., & Goudie, A. J. (1981) · Psychopharmacology · doi:10.1007/bf00426467 · Cited by 170
Drug discrimination studies with MDMA and amphetamine
Oberlender, R. A., & Nichols, D. (1988) · Psychopharmacology · doi:10.1007/bf00212770 · Cited by 152
Self-citation
Research works printed but not linked: 32
- LeBars D., 1987, Appl. Radiat. Isot., 38, 1077
- Kirk K. L, 1975, J. Org. Chem., 41, 2376
- Kirk K. L, 1976, J. Heterocycl. Chem., 13, 1256
- Janssen P. A, 1965, Int. Rev. Neurobiol., 8, 263
- Smart B. E., 1994, Organofluorine Chemistry: Principles and Commercial Applications (Topics in Applied Chemistry), 88
- Park B. K., 1994, Drug Metab. Rev., 26, 643
- Howard J. A. K., 1996, Tetrahedron, 52, 12622
- Bentov M., 1962, J. Chem. Soc., 2825, 2827
- Aldred R., 1994, J. Chem. Soc., Perkin Trans. 1, 1823, 1831
- Adams R. E., 1991, Synth. Commun., 12, 681
- Speeter M. E., 1954, J. Am. Chem. Soc., 76, 6210
- Chen C., 1994, J. Org. Chem., 59, 3741
- Hoggett J. G., 1969, Chem. Commun., 605, 606
- Desaty D., 1964, Croat. Chem. Acta, 36, 109
- Arnt J, 1989, Pharmacol. Toxicol., 64, 172
- Nichols D. E., 1997, Handbook of Experimental Pharmacology. Serotoninergic neurons and 5-HT Receptors in the CNS, 585
- Marona-Lewicka D., 1997, Soc. Neurosci. Abstr., 23
- Kleven M. S., 1997, J. Pharmacol. Exp. Ther., 282, 759
- Darmani N. A., 1996, Pharmacol. Biochem. Behav., 55, 10
- Darmani N. A, 1998, J. Neural Transm., 105, 643
- Strassman R. J, 1996, Behav. Brain Res., 73, 124
- Schreiber R., 1995, J. Pharmacol. Exp. Ther., 273, 112
- Glennon R. A., 1991, Drug Discrimination: Applications to Drug Abuse Research, 44
- Kuipers W., 1994, Drug Des. Discov., 11, 249
- Gallaher T. K., 1993, Med. Chem. Res., 3, 66
- Johnson M. P., 1994, Mol. Pharmacol., 45, 286
- Bergmann E. D., 1959, J. Chem. Soc., 1913, 1914
- Niemann C., 1941, J. Am. Chem. Soc., 63, 611
- Foreman M. M., 1994, J. Pharmacol. Exp. Ther., 270, 1281
- Litchfield J. T., 1949, J. Pharmacol. Exp. Ther., 96, 113
- Berg K. A., 1994, Mol. Pharmacol., 46, 484
- Watts V. J., 1996, Mol. Pharmacol., 50, 976
Cited by
Marine Indole Alkaloids: Potential New Drug Leads for the Control of Depression and Anxiety
Kochanowska-Karamyan, A. J., & Hamann, M. T. (2010) · Chemical Reviews · doi:10.1021/cr900211p · Cited by 2,040
Nichols, D. E. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011478 · Cited by 1,762
Self-citationNichols, D. E. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2003.11.002 · Cited by 1,211
Self-citationThe Concise Guide to PHARMACOLOGY 2013/14: G Protein‐Coupled Receptors
Alexander, S. P. H., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Spedding, M., Peters, J. A., Harmar, A. J., & Collaborators, C. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12445 · Cited by 556
Madsen, M. K., Fisher, P. M., Burmester, D., Dyssegaard, A., Stenbæk, D. S., Kristiansen, S., Johansen, S. S., Lehel, S., Linnet, K., Svarer, C., et al. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0324-9 · Cited by 517
Metadata
- Authors
- Blair, J. B., Kurrasch-Orbaugh, D., Marona-Lewicka, D., Cumbay, M. G., Watts, V. J., Barker, E. L., & Nichols, D. E.
- Affiliations
- Purdue University West Lafayette (US)
- Department of Medicinal Chemistry and Molecular Pharmacology, School of Pharmacy and Pharmacal Sciences, Purdue University, West Lafayette, Indiana 47907
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2000-10-19
- Volume
- 43
- Issue
- 24
- Pages
- 4701-4710
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W1972426098
- Cited by
- 131
- References
- 56
- Citations by year
- 2026: 9 · 2025: 9 · 2024: 7 · 2023: 7 · 2022: 7 · 2021: 5 · 2020: 11 · 2019: 4 · 2018: 5 · 2017: 4 · 2016: 7 · 2015: 6 · 2014: 2 · 2013: 5 · 2012: 5
- FWCI
- 2.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Medicinal Chemistry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Drug Abuse (DA 02189)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- fluorination, 5-HT2A receptor, 5-HT2C receptor, 5-HT1A receptor, drug discrimination, 8-OH-DPAT
- MeSH terms
- Cyclic AMP, Animals, Binding, Competitive, Discrimination Learning, Drug Evaluation, Preclinical, Fluorine, Colforsin, Hallucinogens, Cricetinae, Humans, Hydrolysis, Phosphatidylinositols, Radioligand Assay, Receptors, Serotonin, Structure-Activity Relationship, Tryptamines, CHO Cells, 3T3 Cells, Serotonin Receptor Agonists, Receptors, Serotonin, 5-HT1, Receptor, Serotonin, 5-HT2A, Receptor, Serotonin, 5-HT2C, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.